Temple Research & Innovation retweetledi

Engineered T-cell therapies have transformed treatment for blood cancers. Now they are being used against a solid tumor for the first time, with the newly approved therapy Tecelra showing promise for patients with Synovial Sarcoma. Learn more on @6abc: 6abc.cm/40D71LM

English



















